Hybrid closed-loop insulin delivery — SCE Endocrinology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Assess eligibility for hybrid closed-loop insulin delivery
Hybrid closed-loop therapy may be appropriate in selected adults with type 1 diabetes, particularly where glycaemic targets or hypoglycaemia burden justify it and the person can use the system safely. Basal insulin alone is unsafe in type 1 diabetes. Technology requires ongoing monitoring, education and troubleshooting.
Reference: NICE TA943; NICE NG17